Smith & Nephew’s (SNN) “Buy” Rating Reiterated at Berenberg Bank
Berenberg Bank reissued their buy rating on shares of Smith & Nephew (NYSE:SNN) in a report issued on Friday morning, The Fly reports.
Several other equities research analysts have also recently commented on SNN. BNP Paribas cut Smith & Nephew from a neutral rating to an underperform rating in a report on Friday, June 5th. Citigroup cut Smith & Nephew from a buy rating to a neutral rating in a report on Tuesday, April 14th. Cfra cut their target price on Smith & Nephew from $52.00 to $42.00 and set a hold rating for the company in a research note on Thursday, May 7th. Zacks Investment Research raised Smith & Nephew from a sell rating to a hold rating in a research note on Tuesday, June 2nd. Finally, JPMorgan Chase & Co. reissued a neutral rating on shares of Smith & Nephew in a research note on Thursday, May 7th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the company. Smith & Nephew presently has a consensus rating of Hold and an average price target of $48.00.
NYSE:SNN opened at $38.51 on Friday. Smith & Nephew has a one year low of $26.07 and a one year high of $52.26. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.03 and a current ratio of 2.06. The stock has a market cap of $16.86 billion, a PE ratio of 18.88, a P/E/G ratio of 6.20 and a beta of 0.56. The stock has a 50 day moving average price of $40.45 and a 200 day moving average price of $42.21.
Smith & Nephew Company Profile
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Featured Story: What are the reasons investors use put options?
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.